Aurobindo Pharma Share Price in 1998: Chart, Monthly Trends, & Analysis

How did Aurobindo Pharma shares perform in 1998?

Let's find out!

Aurobindo Pharma share price in 1998 was ₹7.57 Its price on 1st January 1998 was ₹4.47, and by 31st December 1998 it moved to ₹7.57, giving a positive return of 69.35% for the year.

Aurobindo Pharma Share Open, High, Low, and Close prices for the Year 1998 are as follows:

Open	High	Low	Close
₹4.47	₹18.57	₹3.18	₹7.57
1st Jan 1998	Occured in Oct 1998	Occured in Jan 1998	31st Dec 1998

This page will help you understand how Aurobindo Pharma performed in 1998. Let's get started.

For complete insights into Aurobindo Pharma’s incredible stock price performance and growth, see: Aurobindo Pharma Historical Share Price Data from its IPO to 2025

Table: Aurobindo Pharma Share Monthly Close, Low, High Prices for 1998

Month	Aurobindo Pharma	Change%	↑High - ↓Low
Jan	₹3.34	-	↑ ₹4.51 ↓ ₹3.18
Feb	₹4.23	26.6%	↑ ₹4.3 ↓ ₹3.27
Mar	₹3.84	-9.3%	↑ ₹4.38 ↓ ₹3.77
Apr	₹5.33	38.8%	↑ ₹6.83 ↓ ₹3.97
May	₹10.43	95.6%	↑ ₹11.01 ↓ ₹5.33
Jun	₹9.11	-12.6%	↑ ₹10.97 ↓ ₹6.98
Jul	₹13.2	44.7%	↑ ₹13.74 ↓ ₹8.19
Aug	₹12.41	-6%	↑ ₹13.04 ↓ ₹11.3
Sep	₹17.19	38.5%	↑ ₹17.19 ↓ ₹11.8
Oct	₹9.5	-44.8%	↑ ₹18.57 ↓ ₹8.88
Nov	₹7.16	-24.7%	↑ ₹9.52 ↓ ₹6.8
Dec	₹7.57	5.7%	↑ ₹8.18 ↓ ₹6.99

Chart: CandleStick and Line Chart Showing Monthly Prices

[Click on line name to show/hide a line]

What if You invested ₹10,000 in Aurobindo Pharma in 1998?

In 1998, the opening price of Aurobindo Pharma share was ₹4.47. Today, the price stands at ₹1,152.9, reflecting a growth of 25,691.94%. If we applying the same growth to your investment of ₹10,000 then, your investment of ₹10,000 in 1998 would have become ₹25.79 Lakh by 2025. This represents a CAGR of 22.83%.

---

You might also like to check: Aurobindo Pharma Stock Price in 1997 or Aurobindo Pharma Stock Price in 1999

---

References: Stock prices on stockpricearchive.com are gathered from reliable sources only. We take prices from stock exchanges only, majorly from BSE and NSE.

Disclaimer: Information is provided ‘as is’ and solely for informational purposes, not for trading purposes or advice.